Immix Biopharma Inc

NASDAQ IMMX

Data sourced from iex and EODHD
Download Data

Immix Biopharma Inc Income Statement 2020 - 2024

This table shows the Income Statement for Immix Biopharma Inc going from 2020 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30
Revenue
M 0 0 -90 -90 -90 -90 0 0 0 0 0 0 0 0 0
Cost of Revenue
M 0 0 0 - - - - - - - - - - - -
Gross Profit
M 0 0 -90 -90 -90 -90 - - - - - - - - -
Operating Expenses
M 19 16 -75 -86 -86 -86 - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 9 7 7 5 5 4 3 3 2 1 1 0 0 0 0
Research and Development (R&D) Expenses
M 11 9 8 6 5 4 2 1 1 0 0 0 0 0 0
Other Operating Expenses
M 0 0 -90 -90 -90 -90 - - - - - - - - -
Costs and Expenses
M 19 16 15 - - - - - - - - - - - -
Operating Income
M -19 -16 -15 -12 -9 -8 -5 -4 -3 -1 -1 -1 0 0 0
Interest Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 1 1 11 10 10 10 -22 -22 -22 -23 -1 -1 -1 -1 0
EBT
M -18 -16 -14 -11 -9 -8 -27 -26 -25 -24 -2 -2 -2 -1 0
Income Tax Provision
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -18 -16 -14 -11 -9 -8 -27 -26 -25 -24 -2 -2 -2 -1 0
Non-Controlling Interest
M 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0
Net Income
M -4 -7 -11 -12 -10 -8 -27 -26 -25 -25 -2 -2 -1 0 0
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 19,244,475.50 16,859,235.75 15,350,473.75 14,187,078.50 13,897,684.75 13,880,982.25 12,302,905.00 10,621,697.00 9,345,056.50 8,081,176.00 8,081,176.00 8,174,926.00 7,974,950.67 7,575,000.00 7,575,000.00
EBITDA
M -19 -16 -14 -11 -9 -8 -5 -4 -3 -1 -1 -1 -1 -1 0
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -19 -16 -14 -11 -9 -8 -5 -4 -3 -1 -1 -1 -1 -1 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - -
Tax Rate (Effective)
% -0.16 -0.17 -0.17 -0.16 -0.14 -0.12 -0.09 -0.14 -0.31 -0.32 -0.72 -1.02 -1.10 -1.57 -1.50
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit Margin
% 35.70 - 100.00 100.00 100.00 100.00 - - - - - - - - -
Operating Income Margin
% -112,217.60 - 4.24 4.24 4.24 4.24 - - - - - - - - -
Net Income Margin
% - - 4.24 4.24 4.24 4.24 - - - - - - - - -
EBITDA Ratio
% -112,153.22 - 4.24 4.24 4.24 4.24 - - - - - - - - -
EBIT Ratio
% -112,217.52 - 4.24 4.24 4.24 4.24 - - - - - - - - -
EBT Ratio
% -107,593.58 - 4.24 4.24 4.24 4.24 - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email